168 related articles for article (PubMed ID: 36514736)
21. Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.
Mima A; Kitada M; Geraldes P; Li Q; Matsumoto M; Mizutani K; Qi W; Li C; Leitges M; Rask-Madsen C; King GL
FASEB J; 2012 Jul; 26(7):2963-74. PubMed ID: 22499584
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of mitochondrial fission protects podocytes from albumin-induced cell damage in diabetic kidney disease.
Tagaya M; Kume S; Yasuda-Yamahara M; Kuwagata S; Yamahara K; Takeda N; Tanaka Y; Chin-Kanasaki M; Nakae Y; Yokoi H; Mukoyama M; Ishihara N; Nomura M; Araki SI; Maegawa H
Biochim Biophys Acta Mol Basis Dis; 2022 May; 1868(5):166368. PubMed ID: 35202791
[TBL] [Abstract][Full Text] [Related]
23. Macrophages directly mediate diabetic renal injury.
You H; Gao T; Cooper TK; Brian Reeves W; Awad AS
Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1719-27. PubMed ID: 24173355
[TBL] [Abstract][Full Text] [Related]
24. Diabetes-Induced DUSP4 Reduction Promotes Podocyte Dysfunction and Progression of Diabetic Nephropathy.
Denhez B; Rousseau M; Dancosst DA; Lizotte F; Guay A; Auger-Messier M; Côté AM; Geraldes P
Diabetes; 2019 May; 68(5):1026-1039. PubMed ID: 30862678
[TBL] [Abstract][Full Text] [Related]
25. Suppressed ER-associated degradation by intraglomerular cross talk between mesangial cells and podocytes causes podocyte injury in diabetic kidney disease.
Fujimoto D; Kuwabara T; Hata Y; Umemoto S; Kanki T; Nishiguchi Y; Mizumoto T; Hayata M; Kakizoe Y; Izumi Y; Takahashi S; Mukoyama M
FASEB J; 2020 Nov; 34(11):15577-15590. PubMed ID: 32996639
[TBL] [Abstract][Full Text] [Related]
26. Emerging role of podocyte autophagy in the progression of diabetic nephropathy.
Yasuda-Yamahara M; Kume S; Tagawa A; Maegawa H; Uzu T
Autophagy; 2015; 11(12):2385-6. PubMed ID: 26565953
[TBL] [Abstract][Full Text] [Related]
27. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
28. Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.
Zhan H; Jin J; Liang S; Zhao L; Gong J; He Q
Histol Histopathol; 2019 Aug; 34(8):943-952. PubMed ID: 30839094
[TBL] [Abstract][Full Text] [Related]
29. Grem2 mediates podocyte apoptosis in high glucose milieu.
Wen H; Kumar V; Mishra A; Song S; Aslam R; Hussain A; Wang H; Zhou X; He X; Wu G; Luo H; Lan X; Malhotra A; Singhal PC
Biochimie; 2019 May; 160():113-121. PubMed ID: 30831151
[TBL] [Abstract][Full Text] [Related]
30. A KDM6A-KLF10 reinforcing feedback mechanism aggravates diabetic podocyte dysfunction.
Lin CL; Hsu YC; Huang YT; Shih YH; Wang CJ; Chiang WC; Chang PJ
EMBO Mol Med; 2019 May; 11(5):. PubMed ID: 30948420
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Glomerular and Podocyte mRNA Profiles in Streptozotocin-Induced Diabetes.
Fu J; Wei C; Lee K; Zhang W; He W; Chuang P; Liu Z; He JC
J Am Soc Nephrol; 2016 Apr; 27(4):1006-14. PubMed ID: 26264855
[TBL] [Abstract][Full Text] [Related]
32. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
[TBL] [Abstract][Full Text] [Related]
33. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
[TBL] [Abstract][Full Text] [Related]
34. STIM promotes the epithelial-mesenchymal transition of podocytes through regulation of FcγRII activity in diabetic nephropathy.
Jin J; Ye M; Hu K; Gong J; He Q
Histol Histopathol; 2019 Jun; 34(6):671-682. PubMed ID: 30475382
[TBL] [Abstract][Full Text] [Related]
35. Glomerular cell death and inflammation with high-protein diet and diabetes.
Meek RL; LeBoeuf RC; Saha SA; Alpers CE; Hudkins KL; Cooney SK; Anderberg RJ; Tuttle KR
Nephrol Dial Transplant; 2013 Jul; 28(7):1711-20. PubMed ID: 23314315
[TBL] [Abstract][Full Text] [Related]
36. Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes.
Drapeau N; Lizotte F; Denhez B; Guay A; Kennedy CR; Geraldes P
Am J Physiol Endocrinol Metab; 2013 Jun; 304(11):E1188-98. PubMed ID: 23531619
[TBL] [Abstract][Full Text] [Related]
37. The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats.
Zhang X; Song Z; Guo Y; Zhou M
Mol Cell Biochem; 2015 Jan; 399(1-2):155-65. PubMed ID: 25292315
[TBL] [Abstract][Full Text] [Related]
38. Urinary podocyte-derived microparticles in youth with type 1 and type 2 diabetes.
Sullivan KM; Scholey J; Moineddin R; Sochett E; Wicklow B; Elia Y; Xiao F; Mederios T; Sadi P; Burger D; Mahmud FH; Dart AB
Diabetologia; 2021 Feb; 64(2):469-475. PubMed ID: 33037887
[TBL] [Abstract][Full Text] [Related]
39. Research progress on exosomes in podocyte injury associated with diabetic kidney disease.
Li J; Zheng S; Ma C; Chen X; Li X; Li S; Wang P; Chen P; Wang Z; Li W; Liu Y
Front Endocrinol (Lausanne); 2023; 14():1129884. PubMed ID: 37020588
[TBL] [Abstract][Full Text] [Related]
40. Glomerular podocytes in diabetic renal disease.
Podgórski P; Konieczny A; Lis Ł; Witkiewicz W; Hruby Z
Adv Clin Exp Med; 2019 Dec; 28(12):1711-1715. PubMed ID: 31851794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
